NJ
Nathan J Dowden
DELAYED 1 MONTH
President & COO
Entrada Therapeutics, Inc.
Filings
3
Companies
1
Latest
May 4, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
61
TRDACLUSTER 2
Entrada Therapeutics, Inc.
Nathan J Dowden
President & COO
Sale
$230.0K
15,000 sh
May 4 11:24 PM
May 4, 2026
—
Entrada Therapeutics, Inc.
Nathan J Dowden
President & COO
Option Exercise
$26.1K
15,000 sh
May 4 11:24 PM
May 4, 2026
61
TRDACLUSTER 2
Entrada Therapeutics, Inc.
Nathan J Dowden
President & COO
Sale
$155.2K
11,894 sh
Mar 11 8:35 PM
Mar 10, 2026
61
TRDACLUSTER 2
Entrada Therapeutics, Inc.
Nathan J Dowden
President & COO
Sale
$40.6K
3,116 sh
Mar 11 8:35 PM
Mar 9, 2026